-
Diplomat Announces Strong 1st Quarter Financial Results
-
Diplomat Pharmacy (DPLO) PT Raised to $24 at Needham & Company; 'Solid Quarter, CVS Settlement & PBM Acquisition'
-
Diplomat Announces 3rd Quarter Financial Results
-
Diplomat Announces 2nd Quarter Financial Results
-
Diplomat Pharmacy (DPLO) PT Raised to $17 at Cowen; Reiterates Market Perform
-
Diplomat Announces 1st Quarter Financial Results
-
Diplomat Announces 4th Quarter and 2016 Year End Financial Results; Provides Initial 2017 Guidance
-
Diplomat Announces 3rd Quarter Financial Results
-
Diplomat Announces 2nd Quarter Financial Results
-
Diplomat Announces 1st Quarter Financial Results
-
Diplomat Announces 4th Quarter and 2015 Year End Financial Results; Provides Initial 2016 Guidance
-
Diplomat Announces 3rd Quarter Financial Results
-
/C O R R E C T I O N -- Diplomat Pharmacy, Inc./
-
/C O R R E C T I O N -- Diplomat Pharmacy, Inc./
-
UBS Starts Diplomat Pharmacy (DPLO) at Buy
-
Mizuho Securities Cuts Price Target as Recent Sell-offs of Specialty Pharma Manufactures Negatively Effect Diplomat Pharmacy (DPLO)
-
Diplomat Announces 2nd Quarter 2015 Financial Results
-
Diplomat Announces 1st Quarter Financial Results

